Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Tanabe Pharma Corporation
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female, 18 years of age or over
Clinically stable haemodialysis or peritoneal dialysis
Stable phosphate control
On a stabilised phosphorus diet
Female and of child-bearing potential have a negative serum pregnancy test.
Male subjects must agree to use appropriate contraception.
You may not be if
Current clinically significant medical comorbidities, which may substantially compromise subject safety, or expose them to undue risk, or interfere significantly with study procedures and which, in the opinion of the Investigator, makes the subject unsuitable for inclusion in the study.
Body Mass Index (BMI) \<=16.0 kg/m2 or \>=40.0 kg/m2
A current or history of significant gastrointestinal motility problems
A positive test for HIV 1 and 2 antibodies
A history of substance or alcohol abuse within the last year.
Seizure disorders
A history of drug or other allergy
A temporary catheter as a vascular access
Participated in a clinical study with any experimental medication in the last 30 days or an experimental biological product within the last 90 days prior to signing of informed consent
Clareo Health | A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia
